HER2/Neu Positive Recruiting Phase 3 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs